Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK MRI consultation ends Jan 31

This article was originally published in Clinica

Executive Summary

January 31 marks the end of the UK Health Protection Agency's three-month consultation on the protection of patients and volunteers undergoing magnetic resonance imaging (MRI) examinations. The document will form the basis of guidelines updating those issued by the National Radiological Protection Board in 1991. The document is due to be published in March 2008. At the end of 2006, some 500 fixed MRI units were operational at 360 sites across the UK. Unlike CT X-ray (covered by the just-published 12th COMARE report), MRI does not use ionising radiation but needs to be controlled because it produces large static magnetic fields, low frequency (switched gradient) magnetic fields, radio frequency fields and acoustic noise, all of which are potentially harmful, says the HPA.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT045794

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel